Hospital operator Tenet Healthcare (NYSE: THC) will be reporting results this Friday before market open. Here’s what to look for.
Tenet Healthcare met analysts’ revenue expectations last quarter, reporting revenues of $5.37 billion, up 2.8% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates but full-year revenue guidance slightly missing analysts’ expectations.
Is Tenet Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Tenet Healthcare’s revenue to grow 2.8% year on year, in line with the 3.3% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Tenet Healthcare has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Tenet Healthcare’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. UnitedHealth posted flat year-on-year revenue, beating analysts’ expectations by 1.2%, and Elevance Health reported flat revenue, topping estimates by 2.5%. UnitedHealth traded up 1.8% following the results while Elevance Health was down 12.6%.
Read our full analysis of UnitedHealth’s results here and Elevance Health’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 7.9% on average over the last month. Tenet Healthcare is up 10% during the same time and is heading into earnings with an average analyst price target of $243.43 (compared to the current share price of $199.04).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
